Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response

Abstract

Background After the re-emergence of serogroup C meningococcal meningitis (MM) in Nigeria and Niger, we aimed to re-evaluate the vaccination policy used to respond to outbreaks of MM in the African meningitis belt by investigating alternative strategies using a lower incidence threshold and information about neighboring districts. Methods We used data on suspected and laboratory-confirmed cases in Niger and Nigeria from 2013 to 2017. We calculated global and local Moran’s I-statistics to identify spatial clustering of districts with high MM incidence. We used a Pinner model to estimate the impact of vaccination campaigns occurring between 2015 and 2017 and to evaluate the impact of 3 alternative district-level vaccination strategies, compared with that currently used. Results We found significant clustering of high incidence districts in every year, with local clusters around Tambuwal, Nigeria in 2013 and 2014, Niamey, Niger in 2016, and in Sokoto and Zamfara States in Nigeria in 2017. We estimate that the vaccination campaigns implemented in 2015, 2016, and 2017 prevented 6% of MM cases. Using the current strategy but with high coverage (85%) and timely distribution (4 weeks), these campaigns could have prevented 10% of cases. This strategy required the fewest doses of vaccine to prevent a case. None of the alternative strategies we evaluated were more efficient, but they would have prevented the occurrence of more cases overall. Conclusions Although we observed significant spatial clustering in MM in Nigeria and Niger between 2013 and 2017, there is no strong evidence to support a change in methods for epidemic response in terms of lowering the intervention threshold or targeting neighboring districts for reactive vaccination.

Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018

“…In addition, the bacterial meningitis pathogen distribution in the meningitis belt has shown a changing epidemiology in the last 5 years with NmX emergence, NmC expansion (Niger, Nigeria), and pneumococcal outbreaks [22, 23, 27–29]. In 2018, the predominant bacterial meningitis pathogens reported from the meningitis belt were Streptococcus pneumoniae (33%), NmC (24%), NmX (23%), and NmW (5.6%) [30].…”

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017

“…These results also point to the largely unpredictable behavior of N. meningitidis outbreaks [26]. In 2018, a considerable decrease in epidemic activity was reported compared to 2017.…”

“…The applicability of this definition and outbreak thresholds was reviewed in 2014 for NmW outbreaks and was found to be adequate, except for the alert threshold, which was lowered [17, 28]. This was confirmed for NmC outbreaks in 2015 [34], and was recently reevaluated and found applicable [26].…”

Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review

“…Although IMD incidence rates are not formally reported, the onset of recent outbreaks and epidemics in recent years (between 2014 and 2017) highlights the importance of IMD in Nigeria [95][96][97]. In regions most affected by recent outbreaks such as those in the Northwest, cumulative incidence rates exceeding 150 per 100,000 have been reported [96,98].…”